Transvac2 TNA – Open Call for Services

Submit your application for Vaccine Development Services

Si estáis interesados en participar en la propuesta, podéis contactar con la Oficina de Proyectos Europeos del IIS Aragón en internacional@iisaragon.es.

TRANSVAC2 TNA CALL FOR PROPOSALS

​With the pandemic still ongoing, TRANSVAC2 is renewing its commitment to supporting academic and commercial vaccine developers through a new call for proposals dedicated to SARS-CoV-2 / COVID-19, with a special emphasis on variants of concern. Other project proposals will also be considered.You may apply for free-of-charge TNA vaccine development services to advance your research in one of the following main areas:

Technology: Antigen screening, optimization, expression, and production; Adjuvant formulation and characterization (incl. liposomal, mucosal, and parenteral adjuvants); Analytical services offer diverse structural and cellular assays (Now including Luminex potency assay!); GLP/GMP vaccine production using bacterial, yeast, plant, insect, and mammalian platforms

Immunocorrelates/ systems biology: Includes sequencing, cytometry and various -omics services; Statistical analysis and mathematical modelling

Animal models: Services offer a wide range of species and validated disease models, from rodents to NHPs

Clinical trial and regulatory support services: We highly encourage all applicants to request regulatory support alongside scientific technical services, as early assessment of regulatory requirements may prevent unnecessary project delays, reduce costs and ensure adherence to legal requirements.

​Service availability is dependent on budgetary, and timeline constrains and thus subject to change at later stages of the application process. Applicants should contact service providers before submission.

DEADLINE: This call for proposals will remain open until May 31st, 2022. Your proposal will be evaluated, selected and implemented according to the selection process.

For more information about TRANSVAC2 TNA Programme, click here